AlphaCrest Capital Management’s Cytokinetics CYTK Stock Holding History

AlphaCrest Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$279K	Buy
2021 Q3	–	Sell
2021 Q2	$394K	Buy